11 – 20 of 110
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Comparison of two preprocessing methods for 18F-Flortaucipir PET quantification in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Frequency and Clinical Outcomes Associated with Tau Positron Emission Tomography Positivity
- Contribution to journal › Article
- 2024
-
Mark
Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease
- Contribution to journal › Article
-
Mark
Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions
- Contribution to journal › Article
-
Mark
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
- Contribution to journal › Article
-
Mark
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
- Contribution to journal › Article
-
Mark
Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivo
- Contribution to journal › Article
-
Mark
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment
- Contribution to journal › Article
-
Mark
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer's disease
- Contribution to journal › Article
